MARKET

MBX

MBX

MBX Biosciences Inc
NASDAQ
31.66
+0.94
+3.06%
After Hours: 31.66 0 0.00% 16:45 01/09 EST
OPEN
30.96
PREV CLOSE
30.72
HIGH
32.06
LOW
30.52
VOLUME
418.80K
TURNOVER
--
52 WEEK HIGH
35.55
52 WEEK LOW
4.807
MARKET CAP
1.42B
P/E (TTM)
-9.3348
1D
5D
1M
3M
1Y
5Y
1D
Is UBS’s Canvuparatide Focus Altering The Investment Case For MBX Biosciences (MBX)?
Simply Wall St · 2d ago
MBX Biosciences Price Target Announced at $60.00/Share by UBS
Dow Jones · 4d ago
MBX Biosciences Initiated at Buy by UBS
Dow Jones · 4d ago
UBS Initiates Coverage On MBX Biosciences with Buy Rating, Announces Price Target of $60
Benzinga · 4d ago
Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday
Benzinga · 4d ago
MBX Biosciences initiated with a Buy at UBS
TipRanks · 4d ago
U.S. RESEARCH ROUNDUP-Alphabet, Hershey, Micron Technology
Reuters · 4d ago
MBX Biosciences management to meet with Truist
TipRanks · 5d ago
More
About MBX
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. It has built its proprietary Precision Endocrine Peptide platform to develop precision peptide therapies that are designed to overcome key limitations of current peptide therapies. Its product candidates and programs include MBX 2109, MBX 1416 and Obesity portfolio. MBX 2109 is a parathyroid hormone peptide prodrug that is designed as a potential long-acting hormone replacement therapy for the treatment of chronic hypoparathyroidism. MBX 1416 is designed to be a long-acting glucagon-like peptide-1 (GLP-1), receptor antagonist, as a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. MBX 4291 is designed to be a long-acting and highly potent GLP-1 and glucose-dependent insulinotropic polypeptide, receptor co-agonist prodrug.

Webull offers MBX Biosciences, Inc. stock information, including NASDAQ: MBX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBX stock methods without spending real money on the virtual paper trading platform.